| Dr Debra A Strodthoff, MD | |
|
265 Griffin St E, Amery, WI 54001-1439 | |
| (715) 268-8000 | |
| (715) 268-0311 |
| Full Name | Dr Debra A Strodthoff |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 265 Griffin St E, Amery, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679578579 | NPI | - | NPPES |
| 00496 | Other | MEDICARE GROUP | |
| 49170 | Other | MEDICARE GROUP | |
| 1007580 | Other | PREFERRED ONE | |
| 30779000 | Medicaid | WI | |
| 46Q73ST | Other | BCBS MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 26186 (Wisconsin) | Primary |
| Entity Name | Amery Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093763518 PECOS PAC ID: 2769391960 Enrollment ID: O20040131000207 |
News Archive
Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a means by which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Instem, a leading provider of early drug development software solutions, announced today that the National Institute of Environmental Health Sciences has purchased the Provantis® preclinical software solution to support the collection, management and maintenance of the reproductive, perinatal and developmental National Toxicology Program studies. These studies are done predominantly at contractor laboratories at various sites throughout the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Debra A Strodthoff, MD 265 Griffin St E, Amery, WI 54001-1439 Ph: (715) 268-8000 | Dr Debra A Strodthoff, MD 265 Griffin St E, Amery, WI 54001-1439 Ph: (715) 268-8000 |
News Archive
Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a means by which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Instem, a leading provider of early drug development software solutions, announced today that the National Institute of Environmental Health Sciences has purchased the Provantis® preclinical software solution to support the collection, management and maintenance of the reproductive, perinatal and developmental National Toxicology Program studies. These studies are done predominantly at contractor laboratories at various sites throughout the United States.
› Verified 4 days ago
Patricia Lucia Spencer, M.D., M.P.H., M.B.A. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Griffin St E, Amery, WI 54001 Phone: 715-268-8000 | |
Michael J Schneider, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Griffin St E, Amery, WI 54001 Phone: 715-268-8000 Fax: 715-268-0311 | |
Dr. Margie H Peterson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Griffin St E, Amery, WI 54001 Phone: 715-268-8000 Fax: 715-268-0311 | |
Dr. Martin L Rimestad, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 265 Griffin St E, Amery, WI 54001 Phone: 715-268-8000 Fax: 715-268-0311 | |
Kevin G Klein, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Griffin St E, Amery, WI 54001 Phone: 715-268-8000 Fax: 715-268-0311 | |
Dr. Mark R Druffner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Griffin St E, Amery, WI 54001 Phone: 715-268-8000 | |
Haley Combs, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Griffin St E, Amery, WI 54001 Phone: 715-268-8000 |